A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis
Mohammad Shadab Siddiqui, Michael O. Idowu, Dhruvanshu Parmar, Brian B. Borg, Douglas Denham, Nicole Loo, Donald J. Lazas, Ziad Younes, Arun J. Sanyal
Topics & Concepts
MedicineNonalcoholic fatty liver diseaseCirrhosisInternal medicineNonalcoholic steatohepatitisPopulationRandomized controlled trialGastroenterologyFatty liverDiseaseEnvironmental healthLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationLiver Diseases and Immunity